Answers are grounded in this paper and cite their sources.
Observations suggest intracellular pH enhances cancer risk prediction, highlighting its role as a biomarker in cancer cells.
Intracellular pH (pHi) is a tightly regulated biochemical parameter essential for maintaining normal cellular functions, including enzyme activity, cell-cycle progression, and metabolic balance. Persistent alterations in pHi can disrupt the structure and properties of key regulatory enzymes, potentially driving abnormal cell division and contributing to oncogenic transformation. Emerging evidence suggests that cancer cells often exhibit a characteristic shift toward higher intracellular pH and lower extracellular pH, creating a microenvironment that promotes proliferation, invasion, and survival. Therefore, accurate measurement of pHi may offer a valuable biomarker for early detection and risk prediction of cancer. This study proposes the use of intracellular pH as a novel predictive marker, highlighting its potential to improve early diagnosis, enhance risk stratification, and support the development of pH-targeted therapeutic strategies. Further research into reliable pHi measurement techniques may establish pH dysregulation as an important indicator in cancer risk assessment.
No takes yet. Share an insight, caveat, or question.
Umair Masood awan (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: